copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Optimax: Sharpening Focus for a Clearer 2025? | I3investor Optimax Holdings Bhd, after a period of blurred earnings and a 25% share price dip over the past year, is now eyeing a record profit in 2025 Key drivers are new ambulatory care centres (ACCs) and rising demand for premium eye procedures
OPTIMAX (0222) Overview - OPTIMAX HOLDINGS BERHAD | I3investor Optimax Holdings Sdn Bhd is a Malaysia-based company, which provides eye specialist services The Company offers a range of services in medical ophthalmology at its specialist centers The Company provides treatments relating to eye and vision difficulties or impairment covering refractive error, cataract, glaucoma, macular degeneration, diabetic retinopathy and other eye diseases and
OPTIMAX HOLDINGS BERHAD - Navigating Visionary Expansion - I3investor OPTIMAX HOLDINGS BERHAD - Navigating Visionary ExpansionOptimax, holds a pivotal position in the eye care sector, standing as the largest private pure-play provider of eye specialist services in Malaysia Optimax was listed on 18 Aug 2020 in the Ace Market and has completed the transfer of listing to Main Market on 3rd Nov 2022 Optimax has established an extensive geographical presence
TAN SRI DATO DR TAN BOON HOCK @ [OPTIMAX]: OPTIMAX HOLDINGS BERHAD . . . Tan Sri Dato' Dr Tan Boon Hock ("Tan Sri Dato' Dr Tan") ventured into the eye specialist healthcare industry after incorporating Optimax Eye Specialist Centre Sdn Bhd ("OESC") under the name of Precious Premier (M) Sdn Bhd, offering refractive surgery services to patients
Optimax Holdings Berhad - Strategic Regional Expansions Optimax will hire branch managers from Malaysia to oversee operations and local optometrists to support the Vietnam's operation Delayed expansion plans The openings of Kempas Eye Hospital and Setia Alam Hospital have been delayed due to construction setbacks, with completion now expected to be deferred to FY26F onwards
Optimax - ‘Eye’-ing a Comeback | I3investor OPTIMAX anticipates growth in surgery numbers and revenue intensity, driven by refractive surgeries and medical tourism, maintaining a BUY rating with a DCF-TP of MYR0 87
OPTIMAX (0222): OPTIMAX HOLDINGS BERHAD - Overview | I3investor PryorBuyer ROE Recovery in FY25F as Optimax Executes Its Expansion Plans We reiterate Add, with a lower TP of RM0 84 (from RM1 11), based on GGM to better capture its medium-term profitability and growth trajectory